PanGen Biotech Inc (222110) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.33x

PanGen Biotech Inc (222110) has a Cash Flow Reinvestment Rate of 0.33x as of June 2025, reinvesting ₩1.07 Billion (capex ₩56.30 Million plus investments ₩1.01 Billion) from operating cash flow of ₩3.22 Billion. See PanGen Biotech Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.33x

(Capex + Investments) / Operating CF

Total Reinvested

₩1.07 Billion

Capex + Investments

Operating Cash Flow

₩3.22 Billion

KRW

Capital Expenditures

₩56.30 Million

KRW

PanGen Biotech Inc Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for PanGen Biotech Inc across 1 annual periods. For the full cash flow conversion analysis, see PanGen Biotech Inc cash conversion from operations.

Annual Cash Flow Reinvestment Rate for PanGen Biotech Inc (2024–2024)

Year-by-year capital reinvestment analysis for PanGen Biotech Inc. See 222110 financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2024	3.59x	₩10.71 Billion	₩2.99 Billion	₩374.12 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow